Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot...

Area of Science:

• Microbiome research
• Critical care medicine
• Gut health

Background:

• The intestinal microbiota functions as a vital organ influencing human physiology.
• Disruption of the gut microbiota in critically ill patients, particularly by antibiotics, can negatively impact energy metabolism and immunity.
• Understanding these disruptions is crucial for managing critically ill patients.

Purpose of the Study:

• To characterize fecal microbiota composition in critically ill patients with and without sepsis.
• To explore microbiota-derived markers for predicting clinical outcomes in intensive care unit (ICU) patients.

Main Methods:

• Prospective observational cohort study of 34 ICU patients and 15 healthy controls.
• 16S rRNA gene sequencing for phylogenetic characterization of fecal microbiota.
• Evaluation of associations between microbiota composition and clinical outcome parameters.

Main Results:

• All critically ill patients (septic and non-septic) exhibited marked shifts in fecal microbiota compared to controls, with substantial interindividual variation.
• A significant decrease in bacterial diversity was observed in 50% of patients.
• No correlation was found between microbiota diversity, specific bacterial ratios (Firmicutes/Bacteroidetes, Gram-positive/Gram-negative), and clinical outcomes like complications or survival.

Conclusions:

• Critically ill patients display highly heterogeneous intestinal microbiota patterns, regardless of sepsis status.
• Common patterns include the loss of bacterial genera crucial for host metabolism.
• Further research is required to understand the long-term health implications of these significant alterations in gut bacterial communities.